Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors - Top-Institutions - MDSpire

Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors

  • By

  • Sydney T. Grob

  • Kristen R. Miller

  • Bridget Sanford

  • Andrew M. Donson

  • Kenneth Jones

  • Andrea M. Griesinger

  • Vladimir Amani

  • Nicholas K. Foreman

  • Arthur Liu

  • Michael Handler

  • Todd C. Hankinson

  • Sarah Milgrom

  • Jean M. Mulcahy Levy

  • October 25, 2023

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Neuro-Oncology
    • Genetics
    • Neuropsychology

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Oncology
    • Neuro-Oncology
    • Genomic Medicine
    • Neuropsychology

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Neuro-Oncology
    • Genetics
    • Neuropsychology

  • #4

    University of California, San Francisco (UCSF) Benioff Children's Hospitals
    University of California, San Francisco (UCSF) Benioff Children's Hospitals

    San Francisco, CA

    Key Differentiators

    • Pediatric Neuro-Oncology
    • Genetics
    • Neuropsychology

  • #5

    Children’s Hospital Colorado
    Children’s Hospital Colorado

    Aurora, CO

    Key Differentiators

    • Pediatric Neuro-Oncology
    • Genetics
    • Neuropsychology

Original Source(s)

Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors

  • by Sydney T. Grob, Kristen R. Miller, Bridget Sanford, Andrew M. Donson, Kenneth Jones, Andrea M. Griesinger, Vladimir Amani, Nicholas K. Foreman, Arthur Liu, Michael Handler, Todd C. Hankinson, Sarah Milgrom, Jean M. Mulcahy Levy

  • October 25, 2023

Related Content

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Management of toxicities from antibody – drug conjugates in breast cancer